REG - Phoenix Grp Hldgs - Director Declaration

Phoenix groupAnnouncement

10/05/2018 09:30

2018-05-10T08:30:01.52Zreuters.comtag:reuters.com,2018-05-10:newsml_RSJ6363Na:13TXT
This file is provided for EAP sample purposes only; it's structure and detail are subject to change, and should not be used as a definitive reference for actual development and processing.2018-05-10T08:30:01.52Z2018-05-10T08:30:01.52Z____UCDP:parsn_lse_10.54.4.69_1.2.37235:2019-06-10T08:30:01.520Z3RSJ6363NaREG - Phoenix Grp Hldgs  - Director DeclarationLEGACY: Financials (TRBC)Insurance (TRBC level 3)Life & Health Insurance (TRBC level 4)Life & Health Insurance (NEC) (TRBC level 5)Financials (TRBC level 1)Western EuropeUnited KingdomEuropeSuggested SourcesServicesNews AnnouncementsRegulatory Corporate News AnnouncementsCompany NewsEurope daily earnings hits & missesPhoenix Group Holdings








RNS Number : 6363N
Phoenix Group Holdings
10 May 2018
 

 

Phoenix Group Holdings (the "Company" or "Phoenix")
In compliance with Listing Rule 9.6.14, the Company announces that with effect from 9 May 2018, Kory Sorenson, a non-executive director of the Company, has been appointed as a non-executive director of ProMetic Life Sciences Inc., whose shares are listed on the Toronto Stock Exchange.  
 
Enquiries
 
Equity Investors/Analysts:

Claire Hawkins, Head of Investor Relations, Phoenix

+44 (0) 20 3735 0575
 
Media:
Neil Bennett, Maitland

+44 (0) 20 7379 5151
 



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNMMGMKRGNGRZG